Американское общество гирудотерапии

Comparison of the effectiveness of medicinal leech and TENS therapy in the treatment of primary osteoarthritis of the knee: a randomized controlled trial

Isik M, Ugur M, Yakisan RS, Sari T, Yilmaz N (2017) · Zeitschrift für Rheumatologie · n=90

RCT evidence detailTrial reference
GRADE LowCohort / case seriesCondition: Knee Osteoarthritis
Sample size of this trial compared with other Knee Osteoarthritis trialsWang H 2018264Lauche R 2025240Lauche R 2014237Farzali S 2025181Cui Y 2024144Andereya S 2008113Andereya S 2008113Sarbaev IS 201996Isik M 201790Khoshnevisan A 202280
This trial (highlighted) by sample size alongside other indexed Knee Osteoarthritis trials. Larger trials generally carry more statistical weight.

Study Profile

Design
single-center, prospective, randomized, single-blind, parallel-group RCT (Atatürk University, Erzurum, Turkey)
Sample size (n)
90
Intervention
Five Hirudo medicinalis leeches applied to the affected knee once weekly for 3 weeks (leech group, n=46)
Comparator
Transcutaneous electrical nerve stimulation (TENS) therapy following a standardized regimen (TENS group, n=44)
Primary endpoint
Change in pain on VAS and WOMAC scores at days 0, 21, and 180
Primary result
VAS pain score decreased similarly in both groups by day 21 (p<0.001 within-group); between-group course of change in pain similar throughout; all WOMAC subscores decreased similarly in both groups (p=0.819 between-group); long-term (day 180) benefits slightly greater in TENS arm
Follow-up duration
180 days

Key Findings

  • First RCT directly comparing leech therapy with TENS, a widely used non-pharmacologic modality for knee OA
  • Leech therapy produced statistically significant pain and function improvements equivalent to TENS at day 21
  • All WOMAC subscores (pain, stiffness, function) decreased significantly with both modalities through 180 days
  • Long-term benefits modestly favored TENS over leech therapy at the 6-month timepoint
  • Authors conclude leech therapy is a viable alternative or additional non-surgical option for knee OA

Limitations

  • Single center (Atatürk University Faculty of Medicine, Erzurum)
  • Single-blind only — patients aware of intervention
  • TENS comparator parameters not fully described in published methods
  • No NSAID arm — cannot triangulate vs. pharmacologic standard of care
  • Both groups improved significantly, making between-group inference dependent on equivalence assumptions not formally tested

Clinical Implications

Isik 2017 is the largest single-RCT of leech therapy for knee OA published outside Germany (n=90) and the first to use a non-pharmacologic comparator (TENS). The equivalence-level finding is clinically useful: for clinicians and patients choosing between leech and TENS, the trial suggests broadly similar short-term outcomes with TENS having a small long-term edge. The trial supports leech therapy as a reasonable alternative for patients who decline electrotherapy. Methodologically the lack of a pharmacologic comparator limits placement within the wider OA-treatment hierarchy, but the Turkish cohort adds geographic diversity to the European-dominated evidence base.

Related Trials

Этот сайт предоставляет образовательную информацию и не является медицинской консультацией, диагнозом или рекомендацией по лечению. Гирудотерапия сопряжена с клинически значимыми рисками и должна проводиться только квалифицированными клиницистами в рамках институционально утверждённых протоколов. Разрешение FDA 510(k) для медицинских пиявок ограничено определёнными показаниями; обсуждения исследовательского и нелицензионного применения отмечены соответствующим образом. Для индивидуальных медицинских рекомендаций обратитесь к квалифицированному медицинскому специалисту.